Navigation Links
Drug-Device Combination Market Worth US$18.54 Billion by 2014
Date:7/28/2009

WILMINGTON, Delaware, July 28 /PRNewswire/ -- According to a new market research report, 'Drug-Device Combination Market (2009 - 2014)', published by MarketsandMarkets (http://www.marketsandmarkets.com), the total drug-device combination market is expected to be worth US$18.54 billion by 2014, out of which the U.S. market will account for nearly 30.9% of the total revenues. The global market is expected to record a CAGR of 11.8% from 2009 to 2014.

Browse 144 market data tables and in-depth TOC on drug-device market. Early buyers will receive 10% customization of reports

http://www.marketsandmarkets.com/Market-Reports/drug-and-device-combinati

on-101.html

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

The drug-device combination market ( http://www.marketsandmarkets.com/ Market-Reports/drug-and-device-combination-101.html ) includes all the products that are a combination of drugs and devices and can be chemically or physically united or co-packaged as separate, cross labeled products. The market is driven by the growing demand for treating only the ; targeted area, increasing incidences of infections associated with regular medical devices, need for faster healing, and overall reduced cost of treatment and accelerated approval process of the drug-device combination products.

(Due to the length of the URL in the above paragraph, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

The drug eluting stents (DES) market is the larges
'/>"/>

SOURCE MarketsandMarkets
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
2. 96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy
3. Combination Therapy Best for Aggressive Prostate Cancer
4. Particle Sciences Further Expands Combination Product Development Capabilities
5. QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
6. Abbotts TRILIPIX(R) (Fenofibric Acid) in Combination With Rosuvastatin Calcium Helps Patients With Mixed Dyslipidemia and Type 2 Diabetes Meet American Diabetes Association Lipid Targets
7. QLT announces positive results from the evaluation of Visudyne(R) combination therapy
8. 2-drug combination appears safe and active in metastatic kidney cancer
9. New treatment combination proves safe for head and neck cancer patients
10. Study shows drug combination improves outcome for advanced non-small cell lung cancer
11. Chemotherapy combination outcomes differ for aged, younger colon cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... TX (PRWEB) October 22, 2014 On ... Criminal Minds featuring skin diseases both fictional and ... (CEHMDF), a nonprofit organization committed to advocacy and ... if CBS will take the opportunity to impart truth ... , There are many misconceptions about ...
(Date:10/22/2014)... Oct. 21, 2014 (HealthDay News) -- The United ... arriving from Ebola-affected nations of West Africa land ... them for infection with the virus. In ... Johnson noted that 94 percent of air passengers ... at one of these five airports -- New ...
(Date:10/22/2014)... Grants Pass, OR (PRWEB) October 22, 2014 ... while Southern California’s fresh water supply runs dangerously low, ... climate change. Southern Oregon’s rivers, despite the lowest mountain ... fast even in late summer and early autumn.* That ... Urness, authors of the new book “Hiking Southern Oregon,” ...
(Date:10/22/2014)... October 22, 2014 Lintelus, Inc., an ... Vice President of Sales, will be speaking on the ... Technology Expo on October 28, at the Holiday Inn ... a booth as well as a Tech Demo at ... can create a more engaging event experience. , The ...
(Date:10/22/2014)... TUESDAY, Oct. 21, 2014 (HealthDay News) -- Two sisters ... and heart damage. Ilina and Medha Krishen use ... for sounds of trouble in breathing patterns or heartbeats. ... School in Michigan, wanted to find a way to ... air pollutants. Using an electronic stethoscope, Ilina recorded one ...
Breaking Medicine News(10 mins):Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2
... 24 (HealthDay News) -- Exclusive breast-feeding of infants for ... developing the itchy skin disorder known as eczema in ... infant receives only breast milk, with no additional food ... breast-feeding up to 6 months of age is recommended ...
... York, NY, August 24, 2011 Nearly three-quarters (72%) of people ... over the last two years said that they skipped needed ... cost, according to a new Commonwealth Fund report. The ... debt, compared to about half (49%) who lost jobs but ...
... , Governments in the UK, US and Canada are undermining ... smoking, a report by public health researchers says. The paper, ... argues that films with tobacco imagery should be ineligible for ... conflict with public health goals. Earlier research shows that ...
... News) -- Accidental exposure to highly toxic chemotherapy drugs ... a new study finds. Researchers surveyed 1,339 oncology ... infusion centers and found that nearly 17 percent said ... drugs. In the United States, about 84 percent ...
... HealthDay Reporter , TUESDAY, Aug. 23 (HealthDay News) ... jobless men in what,s been dubbed the "mancession" are ... support their working partners, a small study suggests. ... conducted intensive interviews of 19 recently unemployed men. She ...
... , TUESDAY, Aug. 23 (HealthDay News) -- A common ... worsen over time and may lead to an increased risk ... diastolic dysfunction, which often comes with advancing age, the heart,s ... and is accompanied by elevated filling pressures. The new ...
Cached Medicine News:Health News:Breast-Feeding Won't Prevent Kids' Eczema, Researchers Say 2Health News:Three quarters of those who have lost jobs and health insurance are skipping needed health care 2Health News:Three quarters of those who have lost jobs and health insurance are skipping needed health care 3Health News:Three quarters of those who have lost jobs and health insurance are skipping needed health care 4Health News:Government subsidies to the US film industry promote youth smoking, argue researchers 2Health News:Nurses at Risk for Accidental Exposure to Chemo Drugs: Study 2Health News:In Tough Times, Jobless Men Embrace Housework 2Health News:In Tough Times, Jobless Men Embrace Housework 3Health News:Common Heart Dysfunction Can Help Bring on Heart Failure 2
(Date:10/20/2014)... SAN DIEGO , Oct. 20, 2014 /PRNewswire/ ... the availability of the ResMed Data Exchange program, ... for home medical equipment (HME) and other health ... offers timely, secure access to critical patient information. ... from ResMed,s AirView™ and U-Sleep™ patient management platforms ...
(Date:10/20/2014)...   BioNano Genomics announced today achievement of a ... human data at 30X depth, sufficient for a genome map, ... was established and demonstrated for the IrysChip TM V2, ... and will be rolled out to BioNano,s collaborators and ... this advancement at the American Society for Human Genetics ...
(Date:10/20/2014)... PRINCETON, N.J. , Oct. 20, 2014 /PRNewswire/ ... Taiho Pharmaceutical Co., Ltd. ( Japan ... Administration (FDA) granted Fast Track designation for TAS-102 ... combination anticancer drug under investigation for the treatment ... the Company has initiated a rolling NDA submission ...
Breaking Medicine Technology:ResMed Launches ResMed Data Exchange 2BioNano Genomics Announces One Human : One Chip : One Day 2BioNano Genomics Announces One Human : One Chip : One Day 3Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 2Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 3Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 4
... 2012 First Quarter Total Revenue $856 million, including $66 million ... forma organic growth for the combined company, adjusting for the impact ... 2012 First Quarter GAAP EPS Loss of $0.04; Cash EPS ... was $0.99 , 2012 First Quarter GAAP Cash ...
... performance improvement solutions provider GP Strategies Corporation ... quarter ended March 31, 2012. Overview of First ... first quarter of 2012 compared to $64.3 million for first quarter ... quarter of 2012 compared to $4.3 million for first quarter of ...
Cached Medicine Technology:Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 2Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 3Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 4Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 5Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 6Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 7Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 8Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 9Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 10Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 11Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 12Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 13Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 14Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 15Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 16GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 2GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 3GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 4GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 5GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 6
... its wide orifice tip, the Finntip Wide ... suspensions and macromolecules like genomic DNA. This ... cell fragmentation. It is excellent for use ... model, the inside diameter of the orifice ...
... to optimize the accuracy and precision of ... is widely recognized by customers throughout the ... over the years and now covers a ... including filter tips, certified pure tips, stepper ...
MBP's 200 ul large orifice tip is perfect for handling fragile cells, viscous samples and genomic....
... to use: when presented in convenient, ... easy to pick up directly from ... the 96 tips are loaded without ... with a security sticker. Fully autoclavable, ...
Medicine Products: